Report Detail
Global Naltrexone HCL Market Growth 2019-2024
- RnM3051016 |
- 05 March, 2019 |
- Global |
- 134 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Naltrexone HCL is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence.
Naltrexone HCL is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. As a restricted drug, Naltrexone HCL manufacturers are limited. They mainly concentrated in Europe, India, USA and China.
Global naltrexone HCL consumption areas concentrate in Europe, India and USA. Europe is the largest naltrexone HCL consumption area, which took 38.30% in 2015. India also took 21.44% and USA naltrexone HCL consumption took 18.80% of globe.
According to this study, over the next five years the Naltrexone HCL market will register a 0.9% CAGR in terms of revenue, the global market size will reach US$ 21 million by 2024, from US$ 20 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Naltrexone HCL business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Naltrexone HCL market by product type, application, key manufacturers and key regions and countries.
This study considers the Naltrexone HCL value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Naltrexone HCL
Type II
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Opioid Independence
Alcohol Independence
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Taj Pharmaceuticals
Freedom Pharmaceuticals
Rusan
Sanofi
IVAX
Faran Shimi
Sun Pharma
Noramco
Haida Taicheng
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Naltrexone HCL consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Naltrexone HCL market by identifying its various subsegments.
Focuses on the key global Naltrexone HCL manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Naltrexone HCL with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Naltrexone HCL submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Naltrexone HCL Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Naltrexone HCL Consumption 2014-2024
- 2.1.2 Naltrexone HCL Consumption CAGR by Region
- 2.2 Naltrexone HCL Segment by Type
- 2.2.1 Naltrexone HCL
- 2.2.2 Type II
- 2.3 Naltrexone HCL Consumption by Type
- 2.3.1 Global Naltrexone HCL Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Naltrexone HCL Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Naltrexone HCL Sale Price by Type (2014-2019)
- 2.4 Naltrexone HCL Segment by Application
- 2.4.1 Opioid Independence
- 2.4.2 Alcohol Independence
- 2.4.3 Other
- 2.5 Naltrexone HCL Consumption by Application
- 2.5.1 Global Naltrexone HCL Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Naltrexone HCL Value and Market Share by Application (2014-2019)
- 2.5.3 Global Naltrexone HCL Sale Price by Application (2014-2019)
3 Global Naltrexone HCL by Players
- 3.1 Global Naltrexone HCL Sales Market Share by Players
- 3.1.1 Global Naltrexone HCL Sales by Players (2017-2019)
- 3.1.2 Global Naltrexone HCL Sales Market Share by Players (2017-2019)
- 3.2 Global Naltrexone HCL Revenue Market Share by Players
- 3.2.1 Global Naltrexone HCL Revenue by Players (2017-2019)
- 3.2.2 Global Naltrexone HCL Revenue Market Share by Players (2017-2019)
- 3.3 Global Naltrexone HCL Sale Price by Players
- 3.4 Global Naltrexone HCL Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Naltrexone HCL Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Naltrexone HCL Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Naltrexone HCL by Regions
- 4.1 Naltrexone HCL by Regions
- 4.1.1 Global Naltrexone HCL Consumption by Regions
- 4.1.2 Global Naltrexone HCL Value by Regions
- 4.2 Americas Naltrexone HCL Consumption Growth
- 4.3 APAC Naltrexone HCL Consumption Growth
- 4.4 Europe Naltrexone HCL Consumption Growth
- 4.5 Middle East & Africa Naltrexone HCL Consumption Growth
5 Americas
- 5.1 Americas Naltrexone HCL Consumption by Countries
- 5.1.1 Americas Naltrexone HCL Consumption by Countries (2014-2019)
- 5.1.2 Americas Naltrexone HCL Value by Countries (2014-2019)
- 5.2 Americas Naltrexone HCL Consumption by Type
- 5.3 Americas Naltrexone HCL Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Naltrexone HCL Consumption by Countries
- 6.1.1 APAC Naltrexone HCL Consumption by Countries (2014-2019)
- 6.1.2 APAC Naltrexone HCL Value by Countries (2014-2019)
- 6.2 APAC Naltrexone HCL Consumption by Type
- 6.3 APAC Naltrexone HCL Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Naltrexone HCL by Countries
- 7.1.1 Europe Naltrexone HCL Consumption by Countries (2014-2019)
- 7.1.2 Europe Naltrexone HCL Value by Countries (2014-2019)
- 7.2 Europe Naltrexone HCL Consumption by Type
- 7.3 Europe Naltrexone HCL Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Naltrexone HCL by Countries
- 8.1.1 Middle East & Africa Naltrexone HCL Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Naltrexone HCL Value by Countries (2014-2019)
- 8.2 Middle East & Africa Naltrexone HCL Consumption by Type
- 8.3 Middle East & Africa Naltrexone HCL Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Naltrexone HCL Distributors
- 10.3 Naltrexone HCL Customer
11 Global Naltrexone HCL Market Forecast
- 11.1 Global Naltrexone HCL Consumption Forecast (2019-2024)
- 11.2 Global Naltrexone HCL Forecast by Regions
- 11.2.1 Global Naltrexone HCL Forecast by Regions (2019-2024)
- 11.2.2 Global Naltrexone HCL Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Naltrexone HCL Forecast by Type
- 11.8 Global Naltrexone HCL Forecast by Application
12 Key Players Analysis
- 12.1 Taj Pharmaceuticals
- 12.1.1 Company Details
- 12.1.2 Naltrexone HCL Product Offered
- 12.1.3 Taj Pharmaceuticals Naltrexone HCL Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Taj Pharmaceuticals News
- 12.2 Freedom Pharmaceuticals
- 12.2.1 Company Details
- 12.2.2 Naltrexone HCL Product Offered
- 12.2.3 Freedom Pharmaceuticals Naltrexone HCL Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Freedom Pharmaceuticals News
- 12.3 Rusan
- 12.3.1 Company Details
- 12.3.2 Naltrexone HCL Product Offered
- 12.3.3 Rusan Naltrexone HCL Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Rusan News
- 12.4 Sanofi
- 12.4.1 Company Details
- 12.4.2 Naltrexone HCL Product Offered
- 12.4.3 Sanofi Naltrexone HCL Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Sanofi News
- 12.5 IVAX
- 12.5.1 Company Details
- 12.5.2 Naltrexone HCL Product Offered
- 12.5.3 IVAX Naltrexone HCL Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 IVAX News
- 12.6 Faran Shimi
- 12.6.1 Company Details
- 12.6.2 Naltrexone HCL Product Offered
- 12.6.3 Faran Shimi Naltrexone HCL Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Faran Shimi News
- 12.7 Sun Pharma
- 12.7.1 Company Details
- 12.7.2 Naltrexone HCL Product Offered
- 12.7.3 Sun Pharma Naltrexone HCL Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Sun Pharma News
- 12.8 Noramco
- 12.8.1 Company Details
- 12.8.2 Naltrexone HCL Product Offered
- 12.8.3 Noramco Naltrexone HCL Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Noramco News
- 12.9 Haida Taicheng
- 12.9.1 Company Details
- 12.9.2 Naltrexone HCL Product Offered
- 12.9.3 Haida Taicheng Naltrexone HCL Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Haida Taicheng News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Naltrexone HCL . Industry analysis & Market Report on Naltrexone HCL is a syndicated market report, published as Global Naltrexone HCL Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Naltrexone HCL market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
